| __timestamp | Amneal Pharmaceuticals, Inc. | Celldex Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 785623000 | 3586000 |
| Thursday, January 1, 2015 | 866280000 | 5480000 |
| Friday, January 1, 2016 | 1018225000 | 6786000 |
| Sunday, January 1, 2017 | 1033654000 | 12743000 |
| Monday, January 1, 2018 | 1662991000 | 9538000 |
| Tuesday, January 1, 2019 | 1626373000 | 3573000 |
| Wednesday, January 1, 2020 | 1992523000 | 7418000 |
| Friday, January 1, 2021 | 2093669000 | 4651000 |
| Saturday, January 1, 2022 | 2212304000 | 2357000 |
| Sunday, January 1, 2023 | 2393607000 | 6883000 |
Unveiling the hidden dimensions of data
In the competitive world of pharmaceuticals, revenue growth is a key indicator of a company's success. Over the past decade, Amneal Pharmaceuticals, Inc. has demonstrated a remarkable upward trajectory in its annual revenue, growing by over 200% from 2014 to 2023. Starting at approximately $786 million in 2014, Amneal's revenue surged to nearly $2.4 billion by 2023, showcasing its robust market presence and strategic growth initiatives.
In contrast, Celldex Therapeutics, Inc. has experienced a more modest revenue journey. Despite a peak in 2017, where revenue reached around $12.7 million, the company has faced fluctuations, ending 2023 with a revenue of approximately $6.9 million. This comparison highlights the diverse challenges and opportunities within the biotech sector, where innovation and market dynamics play crucial roles in shaping financial outcomes.
Comparing Revenue Performance: Johnson & Johnson or Celldex Therapeutics, Inc.?
Gilead Sciences, Inc. vs Amneal Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Alnylam Pharmaceuticals, Inc. and Amneal Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Exelixis, Inc. and Amneal Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Comparing Revenue Performance: Ascendis Pharma A/S or Celldex Therapeutics, Inc.?
Lantheus Holdings, Inc. vs Amneal Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Revenue Insights: Amneal Pharmaceuticals, Inc. and PTC Therapeutics, Inc. Performance Compared
Amneal Pharmaceuticals, Inc. vs MorphoSys AG: Examining Key Revenue Metrics
Revenue Showdown: Amneal Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
Amneal Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Revenue Insights: Amneal Pharmaceuticals, Inc. and Novavax, Inc. Performance Compared
Breaking Down Revenue Trends: Amphastar Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.